Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Brigham Young University Law School (7916)
- University of Michigan Law School (5842)
- Fordham Law School (4649)
- Duke Law (4618)
- American University Washington College of Law (4014)
-
- William & Mary Law School (3752)
- Yeshiva University, Cardozo School of Law (3654)
- Maurer School of Law: Indiana University (3442)
- UC Law SF (3220)
- Case Western Reserve University School of Law (3158)
- Southern Methodist University (3000)
- University of San Diego (2997)
- Vanderbilt University Law School (2923)
- University of Colorado Law School (2885)
- University of Minnesota Law School (2799)
- Northwestern Pritzker School of Law (2693)
- Notre Dame Law School (2686)
- Seton Hall University (2651)
- University of North Carolina School of Law (2636)
- Loyola University Chicago, School of Law (2577)
- University of Missouri School of Law (2418)
- University of Chicago Law School (2402)
- University of Maryland Francis King Carey School of Law (2367)
- University of Richmond (2348)
- University of South Carolina (2286)
- University of Washington School of Law (2114)
- Columbia Law School (2096)
- University of Oklahoma College of Law (2037)
- Washington and Lee University School of Law (2021)
- University at Buffalo School of Law (1998)
- Keyword
-
- Law (2458)
- Human rights (1494)
- Constitutional law (1351)
- Discrimination (1202)
- Privacy (1168)
-
- Regulation (1165)
- Supreme Court (1124)
- First Amendment (1091)
- Constitutional Law (1089)
- International law (1084)
- United States (1044)
- Environmental law (1010)
- Climate change (991)
- Abortion (956)
- Women (933)
- Legislation (922)
- International Law (836)
- Federalism (809)
- Children (804)
- Constitution (803)
- Ethics (799)
- Criminal law (749)
- Health care (737)
- Education (731)
- COVID-19 (729)
- Administrative law (719)
- Civil rights (701)
- Race (694)
- Torts (691)
- United States Supreme Court (691)
- Publication Year
- Publication
-
- Faculty Scholarship (8299)
- Articles (4057)
- Faculty Publications (3411)
- Michigan Law Review (1987)
- Journal of Criminal Law and Criminology (1845)
-
- Fordham Law Review (1706)
- California Regulatory Law Reporter (1661)
- North Carolina Law Review (1605)
- Utah Court of Appeals Briefs (1996–2006) (1590)
- Scholarly Works (1539)
- Utah Court of Appeals Briefs (through 1995) (1473)
- Law and Contemporary Problems (1455)
- Journal Articles (1272)
- Vanderbilt Law Review (1242)
- Indiana Law Journal (1241)
- SMU Law Review (1193)
- Georgetown Law Faculty Publications and Other Works (1172)
- UC Law Journal (1132)
- West Virginia Law Review (1130)
- St. Mary's Law Journal (1087)
- Louisiana Law Review (1084)
- Faculty Articles (1077)
- Missouri Law Review (1057)
- McGeorge Law Review (1055)
- Minnesota Law Review, Vols. 1-106:1 (1917-2021) (1051)
- Case Western Reserve Law Review (1044)
- Washington and Lee Law Review (1039)
- Cardozo Law Review (1033)
- Washington Law Review (1033)
- Notre Dame Law Review (1018)
- Publication Type
Articles 301 - 330 of 184090
Full-Text Articles in Entire DC Network
History And Tradition Is Not Originalism — Nor A Good Idea, Kermit Roosevelt Iii, Sarah Choudhary
History And Tradition Is Not Originalism — Nor A Good Idea, Kermit Roosevelt Iii, Sarah Choudhary
Seton Hall Journal of Legislation and Public Policy
No abstract provided.
The First Amendment Does Too Much To Protect Child Predators: An Examination Of Child Erotica Under First Amendment Jurisprudence, Michael Fuccile
The First Amendment Does Too Much To Protect Child Predators: An Examination Of Child Erotica Under First Amendment Jurisprudence, Michael Fuccile
Seton Hall Journal of Legislation and Public Policy
No abstract provided.
Modernizing And Clarifying Family Laws: The New Jersey Law Revision Commission’S Examination Of Self-Representation, Domestic Violence, And Parental Rights, Barbara B. Rivera, Whitney G. Schlimbach, Candy Ley Velazquez, Kyle M. Ryan
Modernizing And Clarifying Family Laws: The New Jersey Law Revision Commission’S Examination Of Self-Representation, Domestic Violence, And Parental Rights, Barbara B. Rivera, Whitney G. Schlimbach, Candy Ley Velazquez, Kyle M. Ryan
Seton Hall Journal of Legislation and Public Policy
No abstract provided.
Recreational Cannabis In The Workplace: The Importance Of Implementing Clear Standards For Employers To Determine Whether Employees Are Impaired At Work, Jessica Shinski
Recreational Cannabis In The Workplace: The Importance Of Implementing Clear Standards For Employers To Determine Whether Employees Are Impaired At Work, Jessica Shinski
Seton Hall Journal of Legislation and Public Policy
No abstract provided.
A Dangerous Precedent: How State V. Blevins Fails To Account For Self-Defense In Intimate Partner Violence Scenarios, Arooj Agha
Seton Hall Journal of Legislation and Public Policy
No abstract provided.
Mythbusting Cybersecurity Information Sharing And Antitrust, Terence Check
Mythbusting Cybersecurity Information Sharing And Antitrust, Terence Check
Journal of Business & Technology Law
No abstract provided.
Mandatory Arbitration: Privatizing Justice, And The Quiet Displacement Of The Civil Jury Trial, Leo Clarke
Mandatory Arbitration: Privatizing Justice, And The Quiet Displacement Of The Civil Jury Trial, Leo Clarke
Journal of Business & Technology Law
No abstract provided.
Programmed To Please, Optimized For Obsession, Ela Ender
Programmed To Please, Optimized For Obsession, Ela Ender
Journal of Business & Technology Law
No abstract provided.
Ames V. Ohio Department Of Youth Services: Walking The Disparate Treatment Tightrope, Jonathan Lehr
Ames V. Ohio Department Of Youth Services: Walking The Disparate Treatment Tightrope, Jonathan Lehr
Journal of Business & Technology Law
No abstract provided.
Reimagining The Path Forward: Preparing And Promoting The Next Generation Of Arbitrators Through Innovative Mentorship, Disclosure, And Transparency, Homer C. La Rue
Reimagining The Path Forward: Preparing And Promoting The Next Generation Of Arbitrators Through Innovative Mentorship, Disclosure, And Transparency, Homer C. La Rue
Pepperdine Dispute Resolution Law Journal
The article addresses a pivotal moment for the labor-management arbitration profession. As demographic changes and the growing complexity of labor relations coincide with a decline in the number of qualified arbitration professionals, Professor La Rue emphasizes the critical role senior arbitrators play as mentors and gatekeepers for the next generation. The piece explores mentorship models, including the traditional “Legacy Method” and initiatives designed to expand opportunities for underrepresented groups, such as the Ray Corollary Initiative. The article also offers actionable recommendations to advance disclosure and transparency, including: (1) reducing barriers to entry for new arbitrators; (2) establishing a formal mentorship …
An Open Door Policy: A Contemporary Analysis Of The Continuing Need For Court-Connected Civil Compulsory Arbitration Programs, Joshua D. Rogers
An Open Door Policy: A Contemporary Analysis Of The Continuing Need For Court-Connected Civil Compulsory Arbitration Programs, Joshua D. Rogers
Pepperdine Dispute Resolution Law Journal
Compulsory arbitration could be a crucial instrument in addressing an impending renewed litigation explosion. In the latter half of the twentieth century, numerous courts implemented court-connected civil compulsory arbitration programs to help address the substantial problems created by historic increases in civil litigation. Without much fanfare, these programs have been successfully operating to achieve the goals envisioned at their creation—improving judicial economy and efficiency. Despite the success and longevity in adopting jurisdictions, compulsory arbitration has peaked in its adoption and has seemingly faded into the background of the alternative dispute resolution conversation. Neglecting or dismissing this vital tool in the …
National Security Law, Ogra Cadet, Geoffrey Goodale, Laurence R. Hull, Renee Latour, Barbara Linney, Jonathan Meyer, Guy C. Quinlan, Minji "Mj" Shin, Christopher Vallandingham, Bonnie C. Weinstein
National Security Law, Ogra Cadet, Geoffrey Goodale, Laurence R. Hull, Renee Latour, Barbara Linney, Jonathan Meyer, Guy C. Quinlan, Minji "Mj" Shin, Christopher Vallandingham, Bonnie C. Weinstein
The Year in Review
No abstract provided.
International Animal Law, Tala Dibenedetto, Edie Bowles, Paula Cardoso, Daina Bray, Rajesh K. Reddy, Regina Paulose
International Animal Law, Tala Dibenedetto, Edie Bowles, Paula Cardoso, Daina Bray, Rajesh K. Reddy, Regina Paulose
The Year in Review
No abstract provided.
International Human Rights, Daniel L. Appelman, John Regis Coogan, Cyreka Jacobs, Cailen Labarge, Corinne E. Lewis, Kerry Mclean, Hind Merabet, Linda S. Murnane, Thomas A. O'Keefe, Sara Sandford, Wendy Taube, James Taylor, Constance Z. Wagner
International Human Rights, Daniel L. Appelman, John Regis Coogan, Cyreka Jacobs, Cailen Labarge, Corinne E. Lewis, Kerry Mclean, Hind Merabet, Linda S. Murnane, Thomas A. O'Keefe, Sara Sandford, Wendy Taube, James Taylor, Constance Z. Wagner
The Year in Review
No abstract provided.
Middle East, Kelly Blount, Harry Baumgarten, Nicolas Bremer, Gaurav Redhal, Seyed Mohsen Rowhani, Howard L. Stovall, Catherine Van Kampen
Middle East, Kelly Blount, Harry Baumgarten, Nicolas Bremer, Gaurav Redhal, Seyed Mohsen Rowhani, Howard L. Stovall, Catherine Van Kampen
The Year in Review
No abstract provided.
Women's Interest Network, Julie King, Christine Korper, Abiola Afolayan, Marie Elena Angulo, Michela Cocchi, Angela M. Gallerizzo, Dolly Hernandez, Margaret Kamm, Dana Katz, Kendra Muller, Sierra Paola, Vanessa Romero Rocha, Aina Serret, Sandhya Taneja, Catherine Van Kampen
Women's Interest Network, Julie King, Christine Korper, Abiola Afolayan, Marie Elena Angulo, Michela Cocchi, Angela M. Gallerizzo, Dolly Hernandez, Margaret Kamm, Dana Katz, Kendra Muller, Sierra Paola, Vanessa Romero Rocha, Aina Serret, Sandhya Taneja, Catherine Van Kampen
The Year in Review
No abstract provided.
International Litigation, Jonathan I. Blackman, Carmine D. Boccuzzi, Theodore J. Folkman, Phillip B. Dye Jr., Matthew D. Slater, Mark Mcdonald, Ari Mackinnon, Igor V. Timofeyev, Joseph R. Profaizer
International Litigation, Jonathan I. Blackman, Carmine D. Boccuzzi, Theodore J. Folkman, Phillip B. Dye Jr., Matthew D. Slater, Mark Mcdonald, Ari Mackinnon, Igor V. Timofeyev, Joseph R. Profaizer
The Year in Review
No abstract provided.
International Criminal Law, International Courts, And Judicial Affairs, Manish N. Bhatt, Giovanni Chiarini, Katherine Maddox Davis, Beth Farmer, Timothy Franklin, Cyreka C. Jacobs, Stéphane De Navacelle, Sara L. Ochs, Alexander S. Vesselinovitch, Melissa Ginsberg, Marc Weitz, Julie Zorrilla
International Criminal Law, International Courts, And Judicial Affairs, Manish N. Bhatt, Giovanni Chiarini, Katherine Maddox Davis, Beth Farmer, Timothy Franklin, Cyreka C. Jacobs, Stéphane De Navacelle, Sara L. Ochs, Alexander S. Vesselinovitch, Melissa Ginsberg, Marc Weitz, Julie Zorrilla
The Year in Review
No abstract provided.
International Contracts, Deana Davis, Izak Rosenfeld, Alison Strongwater, Martin E. Aquilina, Vicky Li, Willem Den Hertog
International Contracts, Deana Davis, Izak Rosenfeld, Alison Strongwater, Martin E. Aquilina, Vicky Li, Willem Den Hertog
The Year in Review
No abstract provided.
Mexico, Kelsey Quigley, Josè Luis Lizárraga, John Walsh, Danielle Morris, Maria Camila Hoyos, David Ross, Lauren Mandell, Noah Guiney, Carlo Cannizzo, Enrique García, Vanessa Romero
Mexico, Kelsey Quigley, Josè Luis Lizárraga, John Walsh, Danielle Morris, Maria Camila Hoyos, David Ross, Lauren Mandell, Noah Guiney, Carlo Cannizzo, Enrique García, Vanessa Romero
The Year in Review
No abstract provided.
A Principled Approach To Equitable Compensation Undea Principled Approach To Equitable Compensation Under Erisa § 502(A)(3)R Erisa § 502(A)(3), Gabriel Juedemann
A Principled Approach To Equitable Compensation Undea Principled Approach To Equitable Compensation Under Erisa § 502(A)(3)R Erisa § 502(A)(3), Gabriel Juedemann
University of Chicago Law Review
In many cases, a beneficiary of an employee benefit plan suffers an injury due to a fiduciary’s misfeasance, but the beneficiary does not have a claim under ERISA’s benefit-recovery provision. In these circumstances, the beneficiary’s only path to relief is § 502(a)(3)’s authorization of “appropriate equitable relief.” But whether that provision permits monetary compensation when a beneficiary sues a fiduciary is a question the Supreme Court has not cleanly resolved, and circuit courts have fractured as a result.
This Comment argues that equitable compensation—or surcharge—should be available under § 502(a)(3) when a beneficiary sues a fiduciary, but only under certain …
Ai Slop, Jessica Silbey, Woodrow Hartzog
Ai Slop, Jessica Silbey, Woodrow Hartzog
Faculty Scholarship
The term “AI slop” has become popular to describe the output of generative AI systems seen as voluminous, low quality, or the result of little effort. When AI-generated music and videos flood platforms, they are called slop. Peer-reviewed journals and legal tribunals are drowning in low-quality and low-reliability AI slop submissions. Employees are seen to be producing mountains of slop in their reports and communications with each other. The term has inertia and heft, and the phenomenon has significant consequences. Most of them are not good.
But the boundaries of “AI slop” and its usefulness in policy discussions are not …
Fireproofing The Fda: Power, Politics, And Public Health, Daniel G. Aaron
Fireproofing The Fda: Power, Politics, And Public Health, Daniel G. Aaron
Utah Law Review
On September 26, 2025, the S.J. Quinney College of Law hosted the Lee E. Teitelbaum Utah Law Review Symposium — Fireproofing the FDA: Power, Politics, and Public Health. The symposium is available on YouTube. Participants discussed problems longstanding and new in an attempt to chart a path for this vital agency. Topics included (1) What is the purpose of FDA?; (2) In what ways are the current Administration’s actions precedented or unprecedented?; (3) What is the current and ideal relationship between law and politics?; (4) How can law serve as an agent of public health?; and (5) How do we …
The Fda’S New Clinical Decision Support Software Guidance And Its Implications For Artificial Intelligence, Sara Gerke
The Fda’S New Clinical Decision Support Software Guidance And Its Implications For Artificial Intelligence, Sara Gerke
Utah Law Review
Artificial Intelligence (AI) is transforming healthcare. While the U.S. Food and Drug Administration (FDA) has authorized the marketing of more than 1,400 AI-based products classified as devices under Section 201(h)(1) of the Federal Food, Drug, and Cosmetic Act, many other AIbased products, including certain clinical decision support (CDS) software tools that provide recommendations to health care professionals about diagnosis, treatment, or prevention of a disease or condition, have been placed on the U.S. market without FDA premarket review. On January 6, 2026, the FDA issued a revised CDS Guidance, which superseded the September 28, 2022 CDS Guidance. Shortly after, the …
Fda In 2050: Best- And Worst-Case Scenarios, Michael S. Sinha
Fda In 2050: Best- And Worst-Case Scenarios, Michael S. Sinha
Utah Law Review
In 2025, the Trump administration disrupted many critical aspects of the biomedical research infrastructure in the United States. The Food and Drug Administration (FDA) was not spared. Robert F. Kennedy, Jr., a known vaccine denier with no health care experience, was confirmed as Secretary of the U.S. Department of Health and Human Services (HHS) in February 2025, followed by the confirmation of Dr. Martin Makary as Commissioner of the FDA in April. Departures of long-time FDA scientists, coupled with appointments of key personnel, seemingly because of their public stances on COVID-19 mRNA vaccines, have resulted in a tumultuous year for …
Fda Policymaking In The Trump Deregulation Era, Jordan Paradise J.D.
Fda Policymaking In The Trump Deregulation Era, Jordan Paradise J.D.
Utah Law Review
This Article endeavors to contribute to and continue the conversation about how the Trump deregulatory agenda is impacting a vital national public health agency, the FDA, and our national collective public health in ways that deviate from longstanding agency policy and practice. Various other FDA policy actions deserve concerted attention by legal scholars, including the agency’s recent moves in the direct-to-consumer marketing (DTC) drug space through targeted warning letters and publicity about reforming the “adequate provision” standards, food additives and generally recognized as safe (GRAS) listing processes and directives to industry, adjustments to the biosimilar interchangeability requirements through guidance document, …
Post-Approval Problems, Anjali D. Deshmukh M.D., J.D.
Post-Approval Problems, Anjali D. Deshmukh M.D., J.D.
Utah Law Review
Sitting across from 4-year-old Jessica’s parents, I whispered the truth: the most promising drug to fight their daughter’s disease was a therapy approved for adults, not for children her age. We could estimate the dose, monitor her organs, and hope the toxicity would not outpace the benefits, but there was no high-quality clinical trial data proving it was safe for kids like her yet, despite congressional mandates. Unexpected safety issues are often identified after drugs are approved and used outside of a closely controlled clinical trial, especially in understudied populations like children, the elderly, and pregnant women. When I asked …
Evaluating The Case Against Fda Independence, Patricia J. Zettler, Rachel E. Sachs
Evaluating The Case Against Fda Independence, Patricia J. Zettler, Rachel E. Sachs
Utah Law Review
Many former FDA officials, both politically-appointed leaders and those from the career ranks, as well as numerous FDA scholars have advocated for increased FDA independence in varied forms, and for good reason. At the same time, there are advantages to FDA’s current structure, and there may be ways to insulate career scientific experts’ decisions from political influence and to address other problems by generating independence, without overhauling the agency’s design. Policymakers should consider all options, as particular independence features may, or may not, be the best way, to address concerns about FDA’s capacity to carry out its vital public health …
A Primer Of Medical Device Regulation: How To Go From Reactive To Proactive To Better Protect Patient Safety, Sneha Dave, Rita F. Redberg
A Primer Of Medical Device Regulation: How To Go From Reactive To Proactive To Better Protect Patient Safety, Sneha Dave, Rita F. Redberg
Utah Law Review
FDA oversight of medical devices has too often been reactive, following preventable disasters rather than based on a proactive commitment to patient safety. The history of the device framework, the expansion of expedited pathways, weak postmarket surveillance, broad preemption, and conflicted patient advocacy together create a perfect storm of a regulatory environment that tolerates uncertainty and externalizes costs onto patients. Reforms such as time‑limited breakthrough status, mandatory and enforceable postmarket studies, requirements for more robust safety and efficacy data, and strengthened reporting duty for clinicians would move device regulation closer to FDA’s statutory mandate to protect public health. It would …
Medical Device Regulation: We Can’T Just Go Back (Nor Should We), George Horvath
Medical Device Regulation: We Can’T Just Go Back (Nor Should We), George Horvath
Utah Law Review
For much of the twentieth century, the federal Food and Drug Administration maintained its reputation as the preeminent regulatory agency, renowned for providing vigilant and scientifically rigorous oversight that ensured the safety and effectiveness of drugs and medical devices. But a former FDA commissioner recently lamented that “[t]he FDA as we’ve known it is finished.” Many commentators have raised concerns that reductions in force will leave the Agency understaffed, that these shortages will prolong review times, and that the standards applied to premarket evaluations of medical products will allow unsafe and ineffective products to reach the market. But in the …